Companies / Janux Therapeutics, Inc. / Activity
Activity — Janux Therapeutics, Inc.
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Campbell David Alan CEO | Sell | Common Stock | $110.8K | -8K -2.75% | 284,982 0.47% of shares | medium |
| Jan 2, 2026 | McIver Zachariah Executive | Sell | Common Stock | $37.3K | -3K -10.44% | 23,286 0.04% of shares | low |
| Jan 2, 2026 | DiRaimondo Thomas Executive | Sell | Common Stock | $34.4K | -3K -1.97% | 124,425 0.20% of shares | low |
| Jan 2, 2026 | Winter Charles M. Executive | Sell | Common Stock | $33.0K | -2K -3.00% | 77,721 0.13% of shares | low |
| Jan 2, 2026 | Meyer Andrew Hollman Executive | Sell | Common Stock | $25.8K | -2K -2.21% | 83,095 0.14% of shares | low |
| Jan 2, 2026 | Dobek Maria Executive | Sell | Common Stock | $20.1K | -1K -8.68% | 15,373 0.03% of shares | low |